NCT05112861Phase 3Active not recruiting

A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus Pre-filled Syringe in Subjects With Visual Impairment Due to Retinal Disorders

Study sponsor: Outlook Therapeutics, Inc. · OTLK

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2027-12Estimated

Enrollment · participants120Estimated

Source updated2026-04-22Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-04-22 · 1 field changed

Primary completion date changed

− Before

~~Mar 2025~~

+ After

Dec 2027

Check registry source